Skip to content

A Randomized Controlled Study on the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery by Digital Therapy Electrical Stimulation

A Randomized Controlled Study on the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery by Digital Therapy Electrical Stimulation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103292
Enrollment
Unknown
Registered
2025-05-27
Start date
2024-03-26
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting

Interventions

Test group:30 minutes before surgery, use a Jinzhun wearable programmable electrical stimulation therapy device to stimulate the bilateral Neiguan and Fengchi acupoints for pre-treatment. Within 24 ho
Control group:Using sensory threshold electrical stimulation, the other interventions were the same as the experimental group.

Sponsors

Sanming First Hospital Affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age between 18 and 50 years old (2) Body Mass Index (BMI): 18-24 (3) American Society of Anesthesiologists (ASA) classification I or II (4) PONV risk prediction score Apfel score >=2 points (5) The surgical method is laparoscopic (6) Those who voluntarily participate in the entire process of this study and sign an informed consent form; (7) No mental disorders

Exclusion criteria

Exclusion criteria: (1) Patients with preoperative abnormalities in heart, brain, liver, and kidney function, central system diseases, brain tumors, vestibular dysfunction, Meniere's disease, and severe gastrointestinal diseases (2) Individuals with a history of severe PONV who have received antiemetic medication within one month (3) Individuals with contraindications to electrical stimulation, such as skin allergies, infections, inflammations, etc. at the treatment site (4) Patients with gynecological malignant tumors (5) Individuals with allergies to the drugs used in this study

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomiting incidence rate;

Secondary

MeasureTime frame
Severity of postoperative nausea and vomiting;Postoperative Quality of Recovery Scale for 40 Items (QoR-40 Score);

Countries

China

Contacts

Public ContactJianlong Chen

Sanming First Hospital Affiliated to Fujian Medical University

qmgj@163.com+86 182 5056 2396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026